Guidewire IV Catheters for Catheter Survival
Trial Summary
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Guidewire-assisted intravenous catheter insertion?
Is guidewire-assisted intravenous catheter insertion generally safe for humans?
Guidewire-assisted catheter insertion is generally safe, but there are rare risks such as guidewire retention (when the wire is accidentally left inside the body) and arrhythmias (irregular heartbeats) during the procedure. These risks can be minimized with proper training and safety measures.678910
How is guidewire-assisted intravenous catheter insertion different from other treatments?
Guidewire-assisted intravenous catheter insertion is unique because it uses a guidewire to help place the catheter more accurately and safely, reducing the risk of complications like catheter misplacement or breakage. This method can improve the success rate of catheter placement compared to traditional techniques.2451011
What is the purpose of this trial?
This is a prospective, parallel, non-blinded, two-arm randomized controlled trial of intravenous catheter failure evaluating the impact of a built-in guide wire. The objective of this study is to demonstrate that the control ultralong intravenous catheter (IV) without the guide wire is non-inferior to the experimental catheter with the guide wire. After obtaining consent, eligible patients will be randomly allocated to control Arm 1 (ultralong intravenous catheter) or experimental Arm 2 (ultralong intravenous catheter with guide wire) in a ratio of 1:1 via a computer-generated randomization schedule. The participants will be followed to collect data until the catheter is removed.
Research Team
Amit Bahl, MD
Principal Investigator
William Beaumont Hospitals
Eligibility Criteria
This trial is for clinicians at Corewell Health William Beaumont University Hospital who are trained in vascular access and patients over 18 with a specific Vascular Access Score. Patients must be able to give consent, have no cognitive impairments, skin issues at the IV site, or limited elbow mobility.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the control ultralong intravenous catheter or the experimental catheter with guide wire. Data regarding placement, technique, and clinician experience are collected.
Follow-up
Participants are monitored for catheter functionality, complications, and thrombosis development up to 30 days post discharge.
Treatment Details
Interventions
- Guidewire-assisted intravenous catheter insertion
Find a Clinic Near You
Who Is Running the Clinical Trial?
William Beaumont Hospitals
Lead Sponsor